-
1
-
-
67651209933
-
-
British Pharmacopoeia Commission. 5 1 The Stationery Office London
-
British Pharmacopoeia Commission (2007) British Pharmacopoeia, vol 1, 5th edn. The Stationery Office, London
-
(2007)
-
-
-
3
-
-
33846450691
-
A stability-indicating high performance liquid chromatographic (HPLC) assay for the simultaneous determination of atorvastatin and amlodipine in commercial tablets
-
DOI 10.1016/j.jchromb.2006.09.007, PII S1570023206007495
-
A Mohammadi N Rezanour M Ansari Dogaheh F Ghorbani Bidkorbeh M Hashem RB Walker 2007 J Chromatogr B Analyt Technol Biomed Life Sci 846 215 221 10.1016/j.jchromb.2006.09.007 (Pubitemid 46149520)
-
(2007)
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
, vol.846
, Issue.1-2
, pp. 215-221
-
-
Mohammadi, A.1
Rezanour, N.2
Ansari Dogaheh, M.3
Ghorbani Bidkorbeh, F.4
Hashem, M.5
Walker, R.B.6
-
4
-
-
23444453864
-
Stability indicating RP-HPLC method for simultaneous determination of amlodipine and benazepril hydrochloride from their combination drug product
-
DOI 10.1016/j.jpba.2005.04.001, PII S0731708505002505
-
KR Naidu UN Kale MS Shingare 2005 J Pharm Biomed Anal 39 147 155 10.1016/j.jpba.2005.04.001 (Pubitemid 41112131)
-
(2005)
Journal of Pharmaceutical and Biomedical Analysis
, vol.39
, Issue.1-2
, pp. 147-155
-
-
Naidu, K.R.1
Kale, U.N.2
Shingare, M.S.3
-
5
-
-
0032545350
-
Isocratic, simultaneous reversed-phase high-performance liquid chromatographic estimation of six drugs for combined hypertension therapy
-
DOI 10.1016/S0021-9673(98)00652-9, PII S0021967398006529
-
YP Patel S Patil IC Bhoir M Sundaresan 1998 J Chromatogr A 828 283 286 10.1016/S0021-9673(98)00652-9 (Pubitemid 29046426)
-
(1998)
Journal of Chromatography A
, vol.828
, Issue.1-2
, pp. 283-286
-
-
Patel, Y.P.1
Patil, S.2
Bhoir, I.C.3
Sundaresan, M.4
-
6
-
-
33847092589
-
Determination and pharmacokinetic study of amlodipine in human plasma by ultra performance liquid chromatography-electrospray ionization mass spectrometry
-
DOI 10.1016/j.jpba.2006.11.015, PII S0731708506007503
-
Y Ma F Qin X Sun X Lu F Li 2007 J Pharm Biomed Anal 43 1540 1545 10.1016/j.jpba.2006.11.015 (Pubitemid 46282391)
-
(2007)
Journal of Pharmaceutical and Biomedical Analysis
, vol.43
, Issue.4
, pp. 1540-1545
-
-
Ma, Y.1
Qin, F.2
Sun, X.3
Lu, X.4
Li, F.5
-
8
-
-
24944503562
-
Validated HPLC method for determination of amlodipine in human plasma and its application to pharmacokinetic studies
-
DOI 10.1016/j.farmac.2005.06.012, PII S0014827X0500145X
-
A Zarghi SM Foroutan A Shafaati A Khoddam 2005 Farmaco 60 789 792 10.1016/j.farmac.2005.06.012 (Pubitemid 41317706)
-
(2005)
Farmaco
, vol.60
, Issue.9
, pp. 789-792
-
-
Zarghi, A.1
Foroutan, S.M.2
Shafaati, A.3
Khoddam, A.4
-
10
-
-
0035107754
-
Efficacy and safety of angiotensin receptor blockers: A review of losartan in essential hypertension
-
DOI 10.1016/S0011-393X(01)80019-9
-
Conlin PR (2001) Curr Ther Res Clin Exp 62:673-673. doi: 10.1016/S0011-393X(01)80019-9 (Pubitemid 32222926)
-
(2001)
Current Therapeutic Research - Clinical and Experimental
, vol.62
, Issue.2
, pp. 79-91
-
-
Conlin, P.R.1
-
12
-
-
0037201573
-
Development and validation of a stability-indicating HPLC method for the simultaneous determination of Losartan potassium, hydrochlorothiazide, and their degradation products
-
DOI 10.1016/S0731-7085(02)00385-0, PII S0731708502003850
-
DL Hertzog JF McCafferty X Fang RJ Tyrrell RA Reed 2002 J Pharm Biomed Anal 30 747 760 10.1016/S0731-7085(02)00385-0 (Pubitemid 35279701)
-
(2002)
Journal of Pharmaceutical and Biomedical Analysis
, vol.30
, Issue.3
, pp. 747-760
-
-
Hertzog, D.L.1
McCafferty, J.F.2
Fang, X.3
Tyrrell R.Jeffrey4
Reed, R.A.5
-
15
-
-
0032145787
-
Determination of losartan and its degradates in COZAAR® tablets by reversed-phase high-performance thin-layer chromatography
-
DOI 10.1016/S0731-7085(97)00251-3, PII S0731708597002513
-
KE McCarthy Q Wang EW Tsai RE Gilbert DP Ip MA Brooks 1998 J Pharm Biomed Anal 17 671 677 10.1016/S0731-7085(97)00251-3 (Pubitemid 28302692)
-
(1998)
Journal of Pharmaceutical and Biomedical Analysis
, vol.17
, Issue.4-5
, pp. 671-677
-
-
McCarthy, K.E.1
Wang, Q.2
Tsai, E.W.3
Gilbert, R.E.4
Ip, D.P.5
Brooks, M.A.6
-
18
-
-
0035146858
-
Analysis of binary mixtures of losartan potassium and hydrochlorothiazide by using high performance liquid chromatography, ratio derivative spectrophotometric and compensation technique
-
DOI 10.1016/S0731-7085(00)00434-9, PII S0731708500004349
-
N Erk 2001 J Pharm Biomed Anal 24 603 611 10.1016/S0731-7085(00)00434-9 (Pubitemid 32119576)
-
(2001)
Journal of Pharmaceutical and Biomedical Analysis
, vol.24
, Issue.4
, pp. 603-611
-
-
Erk, N.1
-
21
-
-
0031578698
-
Simple high-performance liquid chromatographic method for determination of losartan and E-3174 metabolite in human plasma, urine and dialysate
-
DOI 10.1016/S0378-4347(97)00489-1, PII S0378434797004891
-
D Farthing D Sica I Fakhry A Pedro TW Gehr 1997 J Chromatogr B Biomed Sci Appl 704 374 378 10.1016/S0378-4347(97)00489-1 (Pubitemid 28021926)
-
(1997)
Journal of Chromatography B: Biomedical Applications
, vol.704
, Issue.1-2
, pp. 374-378
-
-
Farthing, D.1
Sica, D.2
Fakhry, I.3
Pedro, A.4
Gehr, T.W.B.5
-
22
-
-
0037040623
-
Fast screening method for the determination of angiotensin II receptor antagonists in human plasma by high-performance liquid chromatography with fluorimetric detection
-
DOI 10.1016/S0021-9673(01)01496-0, PII S0021967301014960
-
L Gonzalez JA Lopez RM Alonso RM Jimenez 2002 J Chromatogr A 949 49 60 10.1016/S0021-9673(01)01496-0 (Pubitemid 34183413)
-
(2002)
Journal of Chromatography A
, vol.949
, Issue.1-2
, pp. 49-60
-
-
Gonzalez, L.1
Lopez, J.A.2
Alonso, R.M.3
Jimenez, R.M.4
-
23
-
-
0030970607
-
An improved method for the simultaneous determination of losartan and its major metabolite, EXP3174, in human plasma and urine by high-performance liquid chromatography with fluorescence detection
-
DOI 10.1016/S0731-7085(96)01948-6, PII S0731708596019486
-
MA Ritter CI Furtek MW Lo 1997 J Pharm Biomed Anal 15 1021 1029 10.1016/S0731-7085(96)01948-6 (Pubitemid 27199552)
-
(1997)
Journal of Pharmaceutical and Biomedical Analysis
, vol.15
, Issue.7
, pp. 1021-1029
-
-
Ritter, M.A.1
Furtek, C.I.2
Lo, M.-W.3
-
24
-
-
3242684317
-
-
British Hypertension Society 2004 J Fam Pract 53 528 550
-
(2004)
J Fam Pract
, vol.53
, pp. 528-550
-
-
-
25
-
-
9144248446
-
Hypertension Treatment and Control in Five European Countries, Canada, and the United States
-
DOI 10.1161/01.HYP.0000103630.72812.10
-
K Wolf-Maier RS Cooper H Kramer JR Banegas S Giampaoli MR Joffres N Poulter P Primatesta B Stegmayr M Thamm 2004 Hypertension 43 10 17 10.1161/01.HYP.0000103630.72812.10 (Pubitemid 38031904)
-
(2004)
Hypertension
, vol.43
, Issue.1
, pp. 10-17
-
-
Wolf-Maier, K.1
Cooper, R.S.2
Kramer, H.3
Banegas, J.R.4
Giampaoli, S.5
Joffres, M.R.6
Poulter, N.7
Primatesta, P.8
Stegmayr, B.9
Thamm, M.10
-
28
-
-
0037435988
-
Validation of high-performance liquid chromatography methods for pharmaceutical analysis: Understanding the differences and similarities between validation requirements of the US Food and Drug Administration, the US Pharmacopeia and the International Conference on Harmonization
-
DOI 10.1016/S0021-9673(02)01536-4, PII S0021967302015364
-
GA Shabir 2003 J Chromatogr A 987 57 66 10.1016/S0021-9673(02)01536-4 (Pubitemid 36140080)
-
(2003)
Journal of Chromatography A
, vol.987
, Issue.1-2
, pp. 57-66
-
-
Shabir, G.A.1
|